By targeting the retina’s protective barrier, oral Danegaptide could help treat diabetic eye damage earlier, though its lasting benefits remain to be tested. For millions of people with diabetes, treating vision-threatening eye damage means waiting until vision loss has already begun, at which point doctors must deliver regular anti-VEGF injections directly into the eye. These [...]